Complementary Therapies for Diabetes: The Case for Chromium, Magnesium, and Antioxidants
- 1 May 2005
- journal article
- review article
- Published by Elsevier in Archives of Medical Research
- Vol. 36 (3), 250-257
- https://doi.org/10.1016/j.arcmed.2005.01.004
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- Nutrition Principles and Recommendations in DiabetesDiabetes Care, 2004
- Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic β-cellsBiochemical and Biophysical Research Communications, 2002
- Low serum magnesium levels and metabolic syndromeActa Diabetologica, 2002
- Prevention of Hypertension, Insulin Resistance, and Oxidative Stress by α-Lipoic AcidHypertension, 2002
- Low Serum Magnesium Levels and Foot Ulcers in Subjects with Type 2 DiabetesArchives of Medical Research, 2001
- α-Lipoic acid in the treatment of diabetic polyneuropathy in Germany: Current evidence from clinical trialsExperimental and Clinical Endocrinology & Diabetes, 1999
- Peripheral Diabetic NeuropathyDrugs, 1997
- Chromium Oligopeptide Activates Insulin Receptor Tyrosine Kinase ActivityBiochemistry, 1997
- Effects of Vitamin E on Susceptibility of Low-Density Lipoprotein and Low-Density Lipoprotein Subfractions to Oxidation and on Protein Glycation in NIDDMDiabetes Care, 1995
- Determination of intracellular free magnesium by nuclear magnetic resonance in human magnesium deficiency.Journal of the American College of Nutrition, 1989